MGMT and neoplasm: • Retrospective• No data on steroid use, MGMT promoter methylation, IDH mutation status, and post-surgery therapy (patients diagnosed between 2010 and 2013)• Multivariate analysis adjusted for tumor size, grade, KPS, and platelet-to-lymphocyte ratio